(Q31398937)

English

Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 July 2017

Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding (English)

1 reference

Europe PubMed Central

2 July 2017

transmembrane protein

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

N Cotte

1

1 reference

Europe PubMed Central

2 July 2017

M N Balestre

2

1 reference

Europe PubMed Central

2 July 2017

A Aumelas

3

1 reference

Europe PubMed Central

2 July 2017

E Mahé

4

1 reference

Europe PubMed Central

2 July 2017

S Phalipou

5

1 reference

Europe PubMed Central

2 July 2017

D Morin

6

1 reference

Europe PubMed Central

2 July 2017

M Hibert

7

1 reference

Europe PubMed Central

2 July 2017

M Manning

8

1 reference

Europe PubMed Central

2 July 2017

T Durroux

9

1 reference

Europe PubMed Central

2 July 2017

C Barberis

10

1 reference

Europe PubMed Central

2 July 2017

B Mouillac

11

1 reference

Europe PubMed Central

2 July 2017

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

2 July 2017

1 reference

Europe PubMed Central

2 July 2017

267

1 reference

Europe PubMed Central

2 July 2017

4253-4263

1 reference

Europe PubMed Central

2 July 2017

13

1 reference

Europe PubMed Central

2 July 2017

Locating ligand-binding sites in 7TM receptors by protein engineering.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

G protein-coupled receptors. I. Diversity of receptor-ligand interactions.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Identification of residues required for ligand binding to the beta-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

An extracellular residue determines the agonist specificity of V2 vasopressin receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Molecular cloning and expression of a receptor for human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Structure and function of G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

G protein-coupled receptors. II. Mechanism of agonist activation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Constitutively active mutants of rhodopsin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Projection structure of rhodopsin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01472.X

21 January 2018

Identifiers

10.1046/J.1432-1033.2000.01472.X

1 reference

Europe PubMed Central

2 July 2017

1 reference

Europe PubMed Central

2 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31398937&oldid=1544010800"